Our Compounding

Therapeutic Category:

Antifungal Agent

Key Ingredients:

Fluconazole- Interfares with fungal cytochrome P450 activity, decreasing ergosterol synthesis (principal sterol in fungal cell membrane) and inhibiting cell membrane formulation.

Formulation Strength:

Fluconazole 10mg/ml

Pediatric Oral:

• Candidiasis(vaginal, oropharyngeal, esophageal, urinary tract infections, peritonitis,pneumonia & systemic infection).
• Vaginal candidiasis
• Vulvovaginal candidiasis (recurrent).
• Mucosal candidiasis (except genital)
• Tinea capitis
• Tinea pedis, corporis, cruris, pityriasis versicolor /dermal candidiasis
• Invasive candidal infections (candidaemia and disseminated candidiasis)
• Cryptococcal infection(meningitis)
• Prevention of fungal infections in immunocompromised patients
• Prevention of fungal infection in immunocompromised and patiets with high risk of systemic infections e.g following bone marrow transplantation.
• Prevention of relapse of cryptococcal menningitis in HIV infected patients after completion of primary therapy.
• Peritonitis
• Coccidiodomycosis
• Histoplasmosis
• Penicilliosis ; prevention fisrt episode (HIV_exposed/-positive).
• Blastomycosis
• Antifungal prophylaxis in allogeneic bone marrow transplant recipients.

Oral: administer without regard to meals; shake suspension well before use.